Literature DB >> 1842931

Generation of competitor DNA fragments for quantitative PCR.

K Uberla1, C Platzer, T Diamantstein, T Blankenstein.   

Abstract

A convenient and generally applicable method for the generation of competitor DNA fragments for quantitative PCR is described. Using mouse-specific primers, fragments are amplified from DNA of an evolutionarily distantly related species under low-stringency annealing conditions. Because these artificially created fragments contain the mouse primer specific ends, they can be used for the quantification of the mouse DNA amplified by these primers. Competitor DNA fragments that differ in size from the corresponding mouse DNA are selected to distinguish both fragments visually by gel electrophoresis. Competitor DNA fragments were generated for mouse beta-actin, interleukin-1, and tumor necrosis factor (TNF). Co-amplification of beta-actin cDNA for adjustment of equal amounts of input cDNA and subsequently TNF cDNA from lipopolysaccharide (LPS)-activated and nonactivated spleen cells with serial dilutions of the respective competitor DNA fragments allowed a semiquantitative comparison of the ratio of TNF mRNA present in both cDNA samples. Under certain conditions, the competitor DNA fragments can be used to determine the approximate molar concentration of a mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1842931     DOI: 10.1101/gr.1.2.136

Source DB:  PubMed          Journal:  PCR Methods Appl        ISSN: 1054-9803


  10 in total

1.  Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR.

Authors:  J Zhang; C D Byrne
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

2.  Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction.

Authors:  G Deng; M Yu; L C Chen; D Moore; W Kurisu; A Kallioniemi; F M Waldman; C Collins; H S Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients.

Authors:  G M Gallez-Hawkins; B R Tegtmeier; A ter Veer; J C Niland; S J Forman; J A Zaia
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Regulation by non-major histocompatibility complex genes of the allo-4-hydroxy-phenylpyruvate dioxygenase (F liver protein) response.

Authors:  M C Brunner; N A Mitchison
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

5.  Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.

Authors:  S Giguère; J F Prescott
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Mast cells and type VIII collagen in human diabetic nephropathy.

Authors:  B M Rüger; Q Hasan; N S Greenhill; P F Davis; P R Dunbar; T J Neale
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

7.  Gene expression pattern in human monocytes as a surrogate marker for systemic inflammatory response syndrome (SIRS).

Authors:  G Wiegand; K Selleng; M Gründling; R S Jack
Journal:  Mol Med       Date:  1999-03       Impact factor: 6.354

8.  Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro.

Authors:  A J McArthur; A N Coogan; S Ajpru; D Sugden; S M Biello; H D Piggins
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

9.  Quantification in soil and the rhizosphere of the nematophagous fungus Verticillium chlamydosporium by competitive PCR and comparison with selective plating.

Authors:  T H Mauchline; B R Kerry; P R Hirsch
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

10.  Expression of interleukin 10 in human melanoma.

Authors:  S Krüger-Krasagakes; K Krasagakis; C Garbe; E Schmitt; C Hüls; T Blankenstein; T Diamantstein
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.